MX2018013727A - Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias. - Google Patents

Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.

Info

Publication number
MX2018013727A
MX2018013727A MX2018013727A MX2018013727A MX2018013727A MX 2018013727 A MX2018013727 A MX 2018013727A MX 2018013727 A MX2018013727 A MX 2018013727A MX 2018013727 A MX2018013727 A MX 2018013727A MX 2018013727 A MX2018013727 A MX 2018013727A
Authority
MX
Mexico
Prior art keywords
fmd
inflammatory diseases
mimicking diet
fasting mimicking
gastrointestinal autoimmune
Prior art date
Application number
MX2018013727A
Other languages
English (en)
Inventor
D Longo Valter
Young Choi In
Original Assignee
Univ Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Southern California filed Critical Univ Southern California
Publication of MX2018013727A publication Critical patent/MX2018013727A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método para tratar enfermedades autoinmunes y/o inflamatorias incluye un paso de identificar un sujeto que tiene una enfermedad gastrointestinal autoinmune/inflamatoria. Se administra una dieta imitadora del ayuno (FMD) al sujeto durante un primer periodo de tiempo.
MX2018013727A 2016-05-11 2017-05-11 Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias. MX2018013727A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662334733P 2016-05-11 2016-05-11
PCT/US2017/032092 WO2017197076A1 (en) 2016-05-11 2017-05-11 Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.

Publications (1)

Publication Number Publication Date
MX2018013727A true MX2018013727A (es) 2019-08-29

Family

ID=60267379

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013727A MX2018013727A (es) 2016-05-11 2017-05-11 Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.

Country Status (13)

Country Link
US (1) US11540550B2 (es)
EP (1) EP3454867B1 (es)
JP (1) JP2019515009A (es)
KR (1) KR20180136551A (es)
CN (1) CN109152790A (es)
AU (1) AU2017261723B2 (es)
BR (1) BR112018073155A2 (es)
CA (1) CA3024272A1 (es)
ES (1) ES2871060T3 (es)
MX (1) MX2018013727A (es)
RU (1) RU2749436C2 (es)
WO (1) WO2017197076A1 (es)
ZA (1) ZA201808272B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104880428B (zh) * 2015-06-23 2016-07-06 山西振东安特生物制药有限公司 一种胶体果胶铋或含胶体果胶铋制剂中铋含量的测定方法
CN104897668B (zh) * 2015-06-23 2016-08-24 山西振东安特生物制药有限公司 用于检测含胶体果胶铋制剂溶出度的方法
MX2018013727A (es) 2016-05-11 2019-08-29 Univ Southern California Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.
US11284640B2 (en) 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
BR112020018564A2 (pt) * 2018-03-15 2020-12-29 University Of Southern California Composição probiótica para doença gastrointestinal autoimune e/ou inflamatória, uso de uma dieta que simula jejum para prevenir ou tratar doença gastrointestinal autoimune e/ou inflamatória, e suplemento dietário
MX2021005465A (es) * 2018-11-09 2021-12-15 L Nutra Barra nutricional para simular el ayuno intermitente.
WO2021161312A1 (en) * 2020-02-11 2021-08-19 The E. Wolfson Medical Center A method effective for treating ulcerative colitis
TW202236983A (zh) * 2020-12-03 2022-10-01 南加州州立大學 提升骨骼肌再生及強度的模擬禁食生酮飲食(fmd)
US20220175007A1 (en) * 2020-12-09 2022-06-09 University Of Southern California Fasting mimicking ketogenic diet to improve immune function and vaccine response and minimize risk in adults and elderly
WO2023130071A1 (en) * 2021-12-31 2023-07-06 L-Nutra Inc. Fasting-mimicking diet
JP2024036813A (ja) * 2022-09-06 2024-03-18 太田油脂株式会社 機能性食品組成物及びその製造方法
CN117084401A (zh) * 2023-09-05 2023-11-21 浙江大学 Fmd方法在维持衰老肠道稳态方面的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
JP4956002B2 (ja) 2003-12-12 2012-06-20 太陽化学株式会社 腸疾患改善用組成物
US20060235009A1 (en) 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
EP2156188B1 (en) 2007-03-28 2021-05-05 University of Southern California Induction of differential stress resistance and uses thereof
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
RU2392943C2 (ru) 2007-11-22 2010-06-27 Людмила Александровна Орлова Способ разгрузочно-диетической терапии
JP2009263307A (ja) 2008-04-28 2009-11-12 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
CN102753162A (zh) 2009-10-22 2012-10-24 南加利福尼亚大学 增加癌症治疗的效力和降低副作用的方法和营养配方
WO2011139391A1 (en) 2010-04-28 2011-11-10 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
GB201011771D0 (en) 2010-07-13 2010-08-25 Bioinvent Int Ab Biological material and particular uses thereof
WO2012109353A2 (en) 2011-02-08 2012-08-16 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
IN2015DN03796A (es) * 2012-10-17 2015-10-02 Enterome
CA2888811C (en) * 2012-10-22 2023-10-24 University Of Southern California A diet package, and uses thereof
CN114236130A (zh) 2013-02-12 2022-03-25 南加利福尼亚大学 用于减轻年龄相关症状的膳食包装
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
CN105431055A (zh) * 2013-07-01 2016-03-23 南加利福尼亚大学 作为糖尿病食疗的禁食条件
WO2015107514A1 (en) * 2014-01-16 2015-07-23 The E. Wolfson Medical Center A composition and method effective for induction of remission of crohn's disease
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
WO2015153850A2 (en) * 2014-04-02 2015-10-08 University Of Southern California Autoimmunity and multiple sclerosis treatment
WO2016168802A2 (en) 2015-04-16 2016-10-20 University Of Southern California Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone
CN107872958A (zh) 2015-05-06 2018-04-03 南加利福尼亚大学 治疗高血压和脂质紊乱的禁食模仿和加强膳食
CN105431005A (zh) 2015-11-19 2016-03-23 南车株洲电力机车研究所有限公司 一种换热装置
ES2970314T3 (es) 2016-02-15 2024-05-28 Univ Of Southern California Combinaciones de fármacos y métodos para estimular una regeneración similar a la embrionaria para tratar la diabetes
MX2018013727A (es) 2016-05-11 2019-08-29 Univ Southern California Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.

Also Published As

Publication number Publication date
RU2018141550A3 (es) 2020-09-03
ES2871060T3 (es) 2021-10-28
EP3454867A1 (en) 2019-03-20
RU2749436C2 (ru) 2021-06-10
AU2017261723A1 (en) 2018-11-15
WO2017197076A1 (en) 2017-11-16
ZA201808272B (en) 2020-02-26
CA3024272A1 (en) 2017-11-16
EP3454867A4 (en) 2019-12-04
CN109152790A (zh) 2019-01-04
RU2018141550A (ru) 2020-06-11
JP2019515009A (ja) 2019-06-06
AU2017261723B2 (en) 2023-02-09
EP3454867B1 (en) 2021-03-24
KR20180136551A (ko) 2018-12-24
US20170325493A1 (en) 2017-11-16
BR112018073155A2 (pt) 2019-03-12
US11540550B2 (en) 2023-01-03

Similar Documents

Publication Publication Date Title
MX2018013727A (es) Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.
MX2019006864A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de factor de necrosis tumoral (tnf).
EA201790398A1 (ru) Способы лечения заболевания печени
EA201692176A1 (ru) Полифторзамещенное соединение в качестве ингибитора тирозинкиназы брутона (btk)
EA201790180A1 (ru) Способы и терапевтические комбинации для лечения опухолей
MX2021006734A (es) Metodo para tratar el cancer.
MX2019006821A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de cinasa de janus (jak) y dispositivos.
EA201692512A1 (ru) Способы и композиции для лечения синтетическими наноносителями и ингибиторами иммунной контрольной точки
PH12018500578A1 (en) Methods of treating inflammatory diseases
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
NZ723884A (en) Methods of treating alzheimer’s disease
EA201790475A1 (ru) Способы лечения системной красной волчанки с использованием доменного антитела против cd28
MX2018002344A (es) Metodo para tratar el cancer.
MX2015012428A (es) Tratamiento contra enfermedades mediadas th2 por inhibicion de bromodominios.
JO3543B1 (ar) تراكيب حمض أميني إصدار معدل تعطى عن طريق الفم
MX2019014711A (es) Polimeros de union a protones para administracion oral.
IL274541A (en) A method for treating diseases of the digestive tract using Tradifitant
TN2018000188A1 (en) Isoindole compounds
EA201791901A1 (ru) Антагонисты рецептора нейрокинина-3 для терапевтического или косметологического лечения излишних жировых отложений на теле
GB2561300B (en) Method and system for diagnosing disease and generating treatment recommendations
MY195000A (en) Method for the treatment of neurological disease
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
BR112017007860A2 (pt) método para tratar uma doença de gordura no fígado
EP3472181A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF AUTOIMMUNE DISEASES
BR112017001971A2 (pt) ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais?